Home
Sands Capital Life Sciences Pulse Fund II reported a 5.3% stake in Acrivon Therapeutics ACRV · 2,289,271 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 5.3%
- Last report
- 6.8% · filed 25/08/13
- Shares held
- 2,289,271 sh
- Class
- Common Stock, par value $0.001 per share
- Event date
- 26/06/30
- Filed
- 26/08/13
5.3% stake · −1.5pp from the last report
- Stake
- 5.3%
- Last report
- 6.8%
- Since last report
- −1.5pp
Acrivon Therapeutics trades, last 26 weeks
What else happened in Acrivon Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Sands Capital Life Sciences Pulse Fund II's other 5% stake reports
- Sands Capital Life Sciences Pulse Fund II
5% stakeInhibikase Therapeutics
5% stakeInhibikase Therapeutics
IKT
9.3% stake
13,018,965 sh
9.3% stake
Filed 08/13
- Sands Capital Life Sciences Pulse Fund II
5% stakeAlamar Biosciences
5% stakeAlamar Biosciences
ALMR
6.1% stake
4,230,926 sh
6.1% stake
Filed 07/07
- Sands Capital Life Sciences Pulse Fund II
5% stakeAlamar Biosciences
5% stakeAlamar Biosciences
ALMR
6.3% stake
4,230,926 sh
6.3% stake
Filed 04/23
- Sands Capital Life Sciences Pulse Fund II
5% stakeInhibikase Therapeutics
5% stakeInhibikase Therapeutics
IKT
10.8% stake
13,018,965 sh
10.8% stake
Filed 02/13
- Sands Capital Life Sciences Pulse Fund II
5% stakeBeta Bionics
5% stakeBeta Bionics
BBNX
7.3% stake
3,154,409 sh
7.3% stake
Filed 25/04/09
